知镜 Cognispect · 医学文献与研究工作台

Identifying a Cardio-Hepatic Phenotype by Integrating the Albumin-Bilirubin Score Into Risk Assessment in Pulmonary Arterial Hypertension.

Tokgoz HC, Kultursay B, Tanyeri S, Sırma D, Bulus C, Kovanci T, Kara M, Atici SZ, Cicek SN, Cagliyan CE, Kaya A, Akalin F, Sen D, Aliyeva L, Ozdemir N, Kaymaz C.
Pulmonary circulation · 2026-10-16 · PMID 42891253

文献摘要

Risk stratification is essential in pulmonary arterial hypertension (PAH), yet the prognostic utility of the albumin-bilirubin (ALBI) score as a marker of hepatic dysfunction remains underexplored. In this single-center study, we evaluated the clinical, neurohumoral, echocardiographic and hemodynamic correlates and prognostic value of the ALBI score, and to assess whether this score offers an incremental benefit over the Registry to EValuate Early And Long-term pulmonary arterial hypertension disease management (REVEAL) 2.0 risk score in patients with PAH. This study evaluated the prognostic value of the ALBI score and its incremental benefit in a cohort of 380 PAH patients (mean age 47.6 ± 18.3 years, 74.3% female). Patients were stratified into low ( -2.60) ALBI groups. High ALBI scores were significantly associated with worse functional class, reduced exercise capacity, elevated Nt-proBNP, right ventricular systolic dysfunction, and vena cava plethora (all p p = 0.005), reduced cardiac index ( p = 0.002), and a narrowed trans-systemic pressure gradient ( p = 0.001). Multivariable Cox regression demonstrated that ALBI was an independent predictor of mortality [Adjusted HR: 1.80 (95% CI: 1.30-2.49), p p = 0.044], with the full model achieving a C-index of 0.801. Within the REVEAL 2.0 intermediate-risk subgroup, a high ALBI score identified patients with a three-fold higher mortality risk [HR: 3.04 (95% CI: 1.25-7.38), p = 0.014], improving discriminative performance by 26.3%. The ALBI score independently predicts mortality beyond standard pulmonary hemodynamics and echocardiographic right ventricular parameters. Incorporating ALBI into REVEAL 2.0 enhances survival prediction and aids risk refinement in intermediate-risk PAH.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。